RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
93 hedge funds and large institutions have $427M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 40 increasing their positions, 16 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
+7
Holders Change %
+8.14%
% of All Funds
2.13%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
20
Increased
40
Reduced
16
Closed
13
Calls
$2.05M
Puts
$1.02M
Net Calls
+$1.03M
Net Calls Change
+$913K
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
$14.2M |
| 2 |
BlackRock
New York
|
$52.6M |
| 3 |
DM
Deerfield Management
New York
|
$21.3M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
$6.96M |
| 5 |
State Street
Boston,
Massachusetts
|
$11.1M |
